# University of Glasgow

> University of Glasgow is a VC fund in Glasgow backing Biotechnology and Sensor. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Glasgow, United Kingdom
- Total investments: 5
- Last investment: Apr 2025
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/edu/school?id=12666&trk=edu-up-nav-menu-home
- X (Twitter): https://twitter.com/GlasgowUni
- Website: http://www.gla.ac.uk
- Facebook: http://www.facebook.com/glasgowuniversity

University of Glasgow is a VC fund in Glasgow focused on Biotechnology and Sensor. Founded in 1451, the University of Glasgow is the fourth oldest university in the English-speaking world. Today we are in the top 1% of the world's universities.Glasgow’s college system enables interdisciplinary collaboration while fostering a sense of belonging. We have four colleges, each bringing together the research and teachingexpertise of a number of schools and institutes. Every college also has a graduate school.The University is expanding and evolving. Following the closure of the Western Infirmary site in 2015, we plan to invest £80m in new buildings and equipment and £55m on refurbishing facilities over the next five years.

## Contacts

5 contacts available for University of Glasgow. Shizune tracks 11 team members at University of Glasgow. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/university-of-glasgow?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Sensor | 1 | 20% |
| Health Care | 1 | 20% |
| Nanotechnology | 1 | 20% |
| Pharmaceutical | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 2 | 40% |
| Series A | 2 | 40% |
| Seed | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chris Pearce | Professor of Computational Mechanics & Vice Principal (Research) | 0 | https://shizune.co/investors/profile/chris-pearce-2c9d |
| Esther K. Papies | Researcher in Behaviour Change | 0 | https://shizune.co/investors/profile/esther-k-papies |
| Mahmood Adil | Honorary Professor of Health Intelligence and Service Effectiveness | 0 | https://shizune.co/investors/profile/mahmood-adil |
| Paul Siebert | Reader | 0 | https://shizune.co/investors/profile/paul-siebert |
| Phil Trinder | Professor | 0 | https://shizune.co/investors/profile/phil-trinder |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neuranics | Neuranics is a company that creates magnetic sensors that are integrated with semiconductor technology for use in health, fitness, and metaverse applications. Neuranics' proprietary technology detects tiny magnetic impulses from organs of the body using scalable spintronics sensors powered by semiconductors. According to the business, thetechnology could solve the current inadequacies of health monitoring equipment and human-machine interfaces. | $8M | Seed | Apr 09, 2025 |  |
| Solasta Bio | Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection. | $14M | Series A | Sep 11, 2024 |  |
| Clyde Hydrogen Systems | Clyde Hydrogen methods is a technological business that is developing breakthrough methods for large-scale green hydrogen production. | $1.3M | Pre-Seed | Apr 10, 2024 |  |
| Neuranics | Neuranics is a company that creates magnetic sensors that are integrated with semiconductor technology for use in health, fitness, and metaverse applications. Neuranics' proprietary technology detects tiny magnetic impulses from organs of the body using scalable spintronics sensors powered by semiconductors. According to the business, thetechnology could solve the current inadequacies of health monitoring equipment and human-machine interfaces. | $2.5M | Pre-Seed | Sep 27, 2023 |  |
| Clyde Biosciences | Clyde Biosciences – experts in the field of developmental drug testing, giving unique insights into the working mechanisms and actions of drugs under development. | $2.6M | Series A | Apr 13, 2015 |  |

5 of 5 investments shown.

## Co-investors
- [Par Equity](https://shizune.co/investors/profile/par-equity) — VC Fund, 3 deals together
- [Old College Capital](https://shizune.co/investors/profile/old-college-capital) — VC Fund, 2 deals together
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 2 deals together
- [Archangels](https://shizune.co/investors/profile/archangel-informal-investments-limited) — VC Fund, 1 deal together
- [Blackfinch Ventures](https://shizune.co/investors/profile/blackfinch-ventures) — VC Fund, 1 deal together
- [Cavallo Ventures](https://shizune.co/investors/profile/cavallo-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does University of Glasgow invest in?

University of Glasgow invests primarily in Biotechnology, Sensor and Health Care startups, most often at Pre-Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact University of Glasgow?

Public channels for University of Glasgow include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at University of Glasgow?

The team at University of Glasgow includes Chris Pearce (Professor of Computational Mechanics & Vice Principal (Research)), Esther K. Papies (Researcher in Behaviour Change) and Mahmood Adil (Honorary Professor of Health Intelligence and Service Effectiveness), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co